1. Normative value of hyperopia reserve and myopic shift in Chinese children and adolescents aged 3-16 years.
- Author
-
Wang J, Qi Z, Feng Y, Chen J, Du L, Yang J, Xie H, Zhu J, Zou H, He X, and Xu X
- Subjects
- Adolescent, Child, Child, Preschool, Female, Humans, Male, Axial Length, Eye, China epidemiology, Disease Progression, East Asian People, Follow-Up Studies, Reference Values, Hyperopia physiopathology, Hyperopia diagnosis, Myopia physiopathology, Myopia diagnosis, Refraction, Ocular physiology, Visual Acuity physiology
- Abstract
Background: This research aims to generate normative values of hyperopia reserve and refractive progression as effective tools to estimate the risk of myopia., Methods: A 1-year follow-up study was conducted among Chinese children and adolescents aged 3-16 years selected from schools and kinder gardens using cluster sampling. All participants underwent examinations including visual acuity, axial length and cycloplegic autorefraction (1% cyclopentolate). Percentiles of spherical equivalent (SE) were calculated using Lambda-Mu-Sigma (LMS) method. Age-specific refractive progression and hyperopia reserve were determined by backward calculation., Results: Of 3118 participants, 1702 (54.6%) were boys with a mean baseline age of 7.30 years. The 50th percentile of SE estimated by LMS decreased from 1.04 D at 3 years to -2.04 D at 16 years in boys, while from 1.29 D to -2.81 D in girls. The 1-year refractive progression of myopes (0.81 D) was greater than that of non-myopes (0.51 D). The normative value of hyperopia reserve was 2.64 (range: 2.40 D-2.88 D) at 3 years and -0.35 (range: -0.50 to -0.17) D at 16 years, with the maximum progression of 0.35 D at the age of 6 years., Conclusion: Age-specific normative values of hyperopia reserve and yearly myopic shift in children and adolescents aged 3-16 years were provided, helping identify and monitor myopia and giving prevention in advance., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF